Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 5K01DK128128-04
Activation of C/EBP-Ξ² by mitohormesis as a therapy for obesity
National Institutes of Health
Grant: 5R00HG009678-04
Integrating multidimensional genomic data to discover clinically-relevant predictive models
National Institutes of Health
Grant: 2K12GM088010-06
Mentored Experiences in Research, Instruction and Teaching (MERIT) Program
National Institutes of Health
Grant: 5U54DK126087-02
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC)
National Institutes of Health
Grant: 3U54OD030167-04S1
UAB Pilot Center for Precision Animal Modeling (C-PAM)
National Institutes of Health
Grant: 1R03OD030604-01
Using Common Fund data to inform rare disease preclinical models and prioritize drug repurposing
Fields of Study
Keywords
Sustainable Development Goals